Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
0169
Strengths
Insulin aspart 100 [iU]/mL; Insulin human 100 [iU]/mL; Concizumab 100 mg/mL; Dasiglucagon .6 mg/.6mL; Insulin degludec 100 U/mL; Concizumab 40 mg/mL; Nedosiran sodium 160 mg/mL; Nedosiran sodium 128 mg/.8mL; Nedosiran sodium 80 mg/.5mL; Somapacitan 6.7 mg/mL; Somapacitan 3.3 mg/mL; Somapacitan 10 mg/mL; Macimorelin 60 mg/mg; Insulin degludec 100 [iU]/mL; Liraglutide 3.6 mg/mL; Insulin degludec 200 U/mL; Liraglutide 6 mg/mL; Estradiol 10 ug/1; Somatropin 30 mg/3mL; Somatropin 10 mg/1.5mL
Dosage forms
Injection, Solution, Kit, Injection, Suspension, Granule, For solution, Injection, Insert
Routes
Subcutaneous, Intravenous, Oral, Vaginal
Drug classes (FDA established)
Insulin Analog, Insulin, Recombinant Human Growth Hormone, Tissue Factor Pathway Inhibitor Antagonist, Antihypoglycemic Agent, GLP-1 Receptor Agonist, Growth Hormone Secretagogue Receptor Agonist, Estrogen
HCPCS / J-code
None in Med-Code's directory for these products
Package NDCs
105

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Novo Nordisk NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
AlhemoconcizumabConcizumab 100 mg/mLInjection, SolutionSubcutaneous0169-208000169-2080-15—
AlhemoconcizumabConcizumab 100 mg/mLInjection, SolutionSubcutaneous0169-208100169-2081-03—
AlhemoconcizumabConcizumab 40 mg/mLInjection, SolutionSubcutaneous0169-208400169-2084-15—
RivflozanedosiranNedosiran sodium 160 mg/mLInjection, SolutionSubcutaneous0169-530600169-5306-10—
RivflozanedosiranNedosiran sodium 128 mg/.8mLInjection, SolutionSubcutaneous0169-530700169-5307-08—
RivflozanedosiranNedosiran sodium 80 mg/.5mLInjection, SolutionSubcutaneous0169-530800169-5308-01—
ZegaloguedasiglucagonDasiglucagon .6 mg/.6mLInjection, SolutionSubcutaneous0169-191200169-1912-0100169-1912-02—
ZegaloguedasiglucagonDasiglucagon .6 mg/.6mLInjection, SolutionSubcutaneous0169-191300169-1913-0100169-1913-02—
Sogroyasomapacitan-becoSomapacitan 6.7 mg/mLInjection, SolutionSubcutaneous0169-203000169-2030-1100169-2030-90—
Sogroyasomapacitan-becoSomapacitan 3.3 mg/mLInjection, SolutionSubcutaneous0169-203500169-2035-1100169-2035-90—
Sogroyasomapacitan-becoSomapacitan 10 mg/mLInjection, SolutionSubcutaneous0169-203700169-2037-1100169-2037-90—
Rebinyncoagulation factor ix recombinant, glycopegylated—Kit0169-790300169-7903-01—
Macrilenmacimorelin acetateMacimorelin 60 mg/mgGranule, For solutionOral0169-140100169-1401-01—
Novolin Rhuman insulinInsulin human 100 [iU]/mLInjection, SolutionSubcutaneous0169-300300169-3003-1500169-3003-25—
Novolin Nhuman insulinInsulin human 100 [iU]/mLInjection, SuspensionSubcutaneous0169-300400169-3004-1500169-3004-25—
Esperoctantihemophilic factor (recombinant), glycopegylated-exei—Kit0169-850000169-8500-0100169-8500-93—
Esperoctantihemophilic factor (recombinant), glycopegylated-exei—Kit0169-805500169-8055-01—
Esperoctantihemophilic factor (recombinant), glycopegylated-exei—Kit0169-810000169-8100-0100169-8100-93—
Esperoctantihemophilic factor (recombinant), glycopegylated-exei—Kit0169-815000169-8150-01—
Esperoctantihemophilic factor (recombinant), glycopegylated-exei—Kit0169-820000169-8200-01—
Esperoctantihemophilic factor (recombinant), glycopegylated-exei—Kit0169-830000169-8300-0100169-8300-93—
Esperoctantihemophilic factor (recombinant), glycopegylated-exei—Kit0169-840000169-8400-01—
Tresibainsulin degludecInsulin degludec 100 U/mLInjection, SolutionSubcutaneous0169-266200169-2662-1100169-2662-90—
Novolin 70/30human insulinInsulin human 100 [iU]/mLInjection, SuspensionSubcutaneous0169-300700169-3007-1500169-3007-25—
Rebinyncoagulation factor ix recombinant, glycopegylated—Kit0169-790100169-7901-0100169-7901-97—
Rebinyncoagulation factor ix recombinant, glycopegylated—Kit0169-790200169-7902-0100169-7902-97—
Rebinyncoagulation factor ix recombinant, glycopegylated—Kit0169-790500169-7905-0100169-7905-97—
Fiaspinsulin aspart injectionInsulin aspart 100 [iU]/mLInjection, SolutionSubcutaneous0169-320100169-3201-1100169-3201-90—
Fiaspinsulin aspart injectionInsulin aspart 100 [iU]/mLInjection, SolutionSubcutaneous0169-320400169-3204-1500169-3204-97—
Fiaspinsulin aspart injectionInsulin aspart 100 [iU]/mLInjection, SolutionSubcutaneous0169-320500169-3205-1500169-3205-95—
Fiaspinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionSubcutaneous0169-320600169-3206-1500169-3206-95—
Xultophy 100/3.6insulin degludec and liraglutideInsulin degludec 100 [iU]/mL; Liraglutide 3.6 mg/mLInjection, SolutionSubcutaneous0169-291100169-2911-15—
Tresibainsulin degludecInsulin degludec 200 U/mLInjection, SolutionSubcutaneous0169-255000169-2550-1300169-2550-97—
Tresibainsulin degludecInsulin degludec 100 U/mLInjection, SolutionSubcutaneous0169-266000169-2660-1500169-2660-97—
Novoeightantihemophilic factor recombinant—Kit0169-781000169-7810-01—
Novoeightantihemophilic factor recombinant—Kit0169-781500169-7815-01—
Novoeightantihemophilic factor recombinant—Kit0169-782000169-7820-01—
Novoeightantihemophilic factor recombinant—Kit0169-782500169-7825-01—
Novoeightantihemophilic factor recombinant—Kit0169-783000169-7830-01—
Novoeightantihemophilic factor recombinant—Kit0169-785000169-7850-01—
Trettencoagulation factor xiii a-subunit (recombinant)—Kit0169-701300169-7013-01—
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, Subcutaneous0169-6338——
NovoSeven RTcoagulation factor viia (recombinant)—Kit0169-720500169-7205-01—
NovoSeven RTcoagulation factor viia (recombinant)—Kit0169-720800169-7208-01—
NovoSeven RTcoagulation factor viia (recombinant)—Kit0169-720100169-7201-01—
NovoSeven RTcoagulation factor viia (recombinant)—Kit0169-720200169-7202-01—
NovoSeven RTcoagulation factor viia (recombinant)—Kit0169-704000169-7040-01—
VictozaliraglutideLiraglutide 6 mg/mLInjectionSubcutaneous0169-406000169-4060-1200169-4060-1300169-4060-90+1 more—
VagifemestradiolEstradiol 10 ug/1InsertVaginal0169-517600169-5176-0300169-5176-0400169-5176-99—
NorditropinsomatropinSomatropin 30 mg/3mLInjection, SolutionSubcutaneous0169-770300169-7703-2100169-7703-92—

Novo Nordisk: common questions

What is Novo Nordisk's NDC labeler code?
0169. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Novo Nordisk?
Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in